Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures

Please see the October 2013 FDA Drug Safety Communication regarding Potiga and skin discoloration/retinal abnormalities

You'll see patients on Potiga (poe-TEE-ga, ezogabine), a new antiepileptic for partial onset seizures.

It has a unique mechanism...and some unusual side effects.

In fact, the manufacturer is required to have a risk management program to alert prescribers, pharmacists, and patients to the risk of urinary retention.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote